This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (13)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor.—The recent discussion¹ of drug samples and their use by physicians in their practices prompted me to share my observations. In partnership with the pharmaceutical industry, clinicians are given a largess of sample medications. Although the pharmaceutical industry spends an estimated $10 billion each year on drug promotion, little has been written about the (economic) impact on an individual practice.^2-3

In an effort to determine the volume and subsequent retail cost of drugs provided to a busy practice—1 board-certified allergist, 1 nurse practitioner, 3 offices, for a total of 10 office days per week—I surveyed pharmaceutical representatives associated with our practice to provide an inventory of medications given to the practice throughout the previous calendar year. If data were not provided for all 12 months, the information was prorated accordingly.

Eleven pharmaceutical companies (Abbott, Astra, Boehringer Ingelheim, Glaxo Wellcome, Hoechst Marion Roussel, Pfizer, Rhone Poulenc Rorer, Schering, . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

General practitioners and pharmaceutical sales representatives: quality improvement research
Spurling and Mansfield
Qual Saf Health Care 2007;16:266-270.
ABSTRACT | FULL TEXT  

Physician Strategies to Reduce Patients' Out-of-pocket Prescription Costs
Alexander et al.
Arch Intern Med 2005;165:633-636.
ABSTRACT | FULL TEXT